Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,503.20
(
0.00%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
108.51
(
0.24%
)
Bitcoin
67,589.76
(
2.47%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 217104

Tuesday, 02/06/2018 4:14:32 PM

Tuesday, February 06, 2018 4:14:32 PM

Post# of 257302
GILD 4Q17 results/2018 guidance:

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=2330690

GILD’s guidance for 2018 sales from all products is $20-21B, down from $25.7B in 2017.

There is no guidance for 2018 HCV sales in the above PR, but there probably will be on today’s CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today